VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
INGNInogen, Inc.
$6.94$188M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksINGNCash Flow

Inogen, Inc. (INGN) Cash Flow Statement

15Y historyFree accessUpdated daily

Cash conversion remains structurally disconnected, as evidenced by a negative operating cash flow of $6.7 million in 2026Q1 despite a net loss of $8.3 million.

INGN Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Cash from Operations-1.11M-11.22M5.91M-3.23M-37.53M23.63M37.01M40.59M59.98M60.49M31.03M38.16M15.7M13.47M4M1.86M
Operating CF Margin %--3.22%1.76%-1.02%-9.95%6.6%12%11.22%16.75%24.25%15.3%24%13.95%17.85%8.24%6.07%
Operating CF Growth %24.96%-289.65%282.87%91.38%-258.81%-36.15%-8.82%-32.32%-0.85%94.93%-18.68%143.11%16.56%236.34%115.38%-
Net Income-24.9M-22.75M-35.89M-102.45M-83.77M-6.33M-5.83M20.95M51.84M21M20.52M11.59M6.83M25.43M564K-2M
Depreciation & Amortization20.37M20.66M21M18.15M23.51M21.63M18.58M13.83M11.29M12.3M13.56M14.01M12.08M8.54M4.98M3.2M
Stock-Based Compensation5.87M8.01M7.4M7.43M12.28M10.94M8.2M9.13M12.79M9.64M7.29M3.64M1.45M230K60K144K
Deferred Taxes-1.6M-1.1M-1.15M-251K014.44M-82K2.87M-11.6M7.95M1.04M4.76M1.56M-21.79M3K0
Other Non-Cash Items13.02M10.87M18.94M59.62M55.16M3.02M16.17M21.69M21.29M20.24M22.92M19.09M13.46M11.09M1.27M3.72M
Working Capital Changes-13.88M-26.91M-4.39M14.27M-44.72M-20.07M-31K-27.89M-25.65M-10.64M-34.3M-14.92M-19.69M-10.04M-2.87M-3.2M
Change in Receivables-11.95M-14.62M-5.07M11.13M-51.62M-5.42M-7.25M-17.03M-25.96M-18.26M-32.74M-16.7M-22.16M-13.63M-3.76M-4.06M
Change in Inventory-4.11M-3.21M-3.54M7.88M-5.6M-10.78M7.59M-10.34M-9.97M-5.89M-7.46M-2.57M-3.57M-267K-2.44M109K
Change in Payables-2.63M5.6M-3.41M-9.18M6.76M-6.48M-5.83M3.2M6.36M7.44M-86K1.58M3.64M2.15M2.6M340K
Cash from Investing-26.15M-26.21M-13.97M-59.31M-10.88M-14.64M-25.64M-44.06M-24.96M-24.43M-11.93M-29.3M-16.25M-18.14M-12.47M-8.92M
Capital Expenditures-9.13M-10.38M0-27.01M-21.22M-24.07M-17.6M-6.26M-12.97M-10.23M-8.02M-12.49M-16.24M-18.14M-12.45M-8.96M
CapEx % of Revenue2.6%2.98%5.09%8.56%5.63%6.72%5.7%1.73%3.62%4.1%3.95%7.85%14.43%24.05%25.63%29.25%
Acquisitions000-29.43M331K153K163K-70.4M350K-4.49M-113K45K0000
Investments----------------
Other Investing00-16.82M0000-60K365K183K501K-45K-222K-37K-27K42K
Cash from Financing-1.89M24.18M265K960K380K15M2.07M4.93M18.3M14M7.71M381K43.87M3.08M19.68M5.18M
Debt Issued (Net)0000000000-315K-299K-10.07M1.79M-693K5.13M
Equity Issued (Net)-1.02M28.18M811K1.48M1.74M15.65M2.42M0000051.89M019.95M0
Dividends Paid0000000000000000
Share Repurchases-1.87M0000000-1.21M0000000
Other Financing-873K-4M-546K-518K-1.35M-647K-350K4.93M18.3M14M8.03M680K2.05M1.3M425K47K
Net Change in Cash-28.13M-12.4M-8.08M-61.52M-48.51M23.56M13.93M1.4M53.68M50.1M26.75M9.27M43.31M-1.59M11.21M-1.88M
Free Cash Flow-10.24M-21.6M-11.18M-29.75M-58.75M-302K19.67M34.08M47M50.27M23.02M25.67M-540K-4.67M-8.44M-7.1M
FCF Margin %-2.91%-6.19%-3.33%-9.43%-15.57%-0.08%6.38%9.42%13.13%20.15%11.35%16.15%-0.48%-6.2%-17.38%-23.18%
FCF Growth %51.55%-93.21%62.42%49.36%-19354.97%-101.54%-42.28%-27.5%-6.49%118.38%-10.34%4854.07%88.45%44.64%-18.91%-
FCF per Share-0.37-0.79-0.47-1.28-2.57-0.010.891.532.092.301.091.24-0.03-0.26-0.52-0.43
FCF Conversion (FCF/Net Income)0.41x0.49x-0.16x0.03x0.45x-3.73x-6.35x1.94x1.16x2.88x1.51x3.29x2.30x0.53x7.10x-0.93x
Interest Paid0000000000026K487K552K462K258K
Taxes Paid84K0375K0000239K1.65M1.27M019K2.06M311K37K16K

Key Metrics

Growth RegimeDecelerating
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

High customer acquisition costs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Remains Structurally Disconnected

Based on reported financial statements, Inogen's operating cash flow frequently diverges from net income, with the company recording a net loss of $8.3 million in 2026Q1 while simultaneously reporting a negative operating cash flow of $6.7 million, highlighting a persistent inability to convert accounting earnings into cash.

The consistent gap between net income and operating cash flow suggests that the company's accrual-based losses are not merely accounting artifacts but reflect genuine cash outflows required to sustain operations. Investors should monitor whether the reliance on non-cash adjustments like depreciation and stock-based compensation masks a deeper structural issue in the company's core profitability.

Free Cash Flow Volatility Persists

As indicated by recent quarterly filings, Inogen's free cash flow trajectory remains highly erratic, swinging from a negative $18.8 million in 2025Q1 to a positive $64,000 in 2025Q3, which underscores the difficulty in achieving a sustainable cash-generative state within the current direct-to-consumer business model.

The lack of a clear upward trend in free cash flow suggests that the company's capital requirements for its rental fleet and marketing initiatives continue to outpace its ability to generate internal liquidity. This volatility warrants further investigation into whether the business can reach a self-funding inflection point without further dilutive financing.

Working Capital Swings Impair Liquidity

According to the cash flow data, Inogen experienced a significant working capital drain of $21.3 million in 2025Q1, a development that suggests the company's cash management is highly sensitive to inventory build-ups and the timing of receivables collection within its complex distribution network.

The erratic nature of these working capital changes implies that the company may be struggling to optimize its inventory levels relative to fluctuating demand for its portable oxygen concentrators. Such fluctuations create unnecessary pressure on the balance sheet, potentially forcing management to prioritize short-term liquidity over long-term strategic investments.

Capital Intensity Remains A Burden

Based on the provided figures, Inogen's capital expenditure as a percentage of revenue reached as high as 8.3% in 2023Q4, indicating that the company must continuously reinvest in its rental fleet and manufacturing capabilities just to maintain its current market position.

The persistent need for capital expenditure, even during periods of negative operating cash flow, suggests that the business model is inherently capital-intensive. This dynamic limits the company's financial flexibility and suggests that any future growth will require significant upfront investment that may not be immediately accretive to cash flow.

Limited Capital Allocation Flexibility Observed

As reported in recent filings, Inogen's capital deployment has been largely constrained by its operating losses, with share repurchases totaling only $1.9 million in 2026Q1, a figure that appears modest given the company's stated goal of maintaining a stable and conservative balance sheet.

The limited scope of capital deployment suggests that management is prioritizing the preservation of its cash position over aggressive shareholder returns or large-scale acquisitions. This cautious approach appears prudent given the ongoing cash burn, but it also raises questions about the company's ability to pivot toward inorganic growth if organic efforts continue to falter.

INGN — Frequently Asked Questions

Quick answers to the most common questions about buying INGN stock.

How much cash does Inogen, Inc. (INGN) generate from operations?

Inogen, Inc. (INGN) generated $-11.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Inogen, Inc.'s free cash flow?

Inogen, Inc. (INGN) reported negative free cash flow of $21.6M in 2025, indicating capital requirements exceeded cash from operations.

What is Inogen, Inc.'s capital expenditure (CapEx)?

Inogen, Inc. (INGN) spent $10.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.